Rheumatic heart disease in Queensland, Western Australia, South Australia and the Northern Territory

As New South Wales uses different inclusion criteria, it is not comparable to the other 4 jurisdictions and so results for New South Wales are shown separately at the end of this chapter.

Rheumatic heart disease is more common in First Nations people

At 31 December 2024, 7,510 people were recorded as having RHD on registers in Queensland, Western Australia, South Australia, and the Northern Territory (Supplementary table 4.1b). Of these:

The prevalence of RHD increased for First Nations people and all Australians over time (Figure 4.4; Supplementary tables 4.5a and 4.5b). 

Figure 4.1: Prevalence of RHD, by Indigenous status and age, as at 31 December 2024

The prevalence of RHD among First Nations people peaks at 35–44 years.

Source: AIHW analysis of National Rheumatic Heart Disease data collection. https://www.aihw.gov.au

Downloadable data tables are available on Data. See tables 4.1a and 4.1b.

Figure 4.2: Prevalence of RHD among First Nations people, by state or territory of management, 2024

Queensland, Western Australia, and South Australia had similar prevalence rates while the Northern Territory was much higher.

Source: AIHW analysis of National Rheumatic Heart Disease data collection. https://www.aihw.gov.au

Downloadable data tables are available on Data. See Table 4.2.

Figure 4.3: Distribution of population and RHD cases by remoteness, First Nations people in Qld, WA, SA, and NT, 2024

Far more RHD cases were managed in Remote and very remote areas compared to the population who live remotely.

Far more RHD cases were managed in Remoteand very remote areas compared to the population who live remotely.

Source: AIHW analysis of National Rheumatic Heart Disease data collection. https://www.aihw.gov.au

Downloadable data tables are available on Data. See Table 4.3.

Figure 4.4: Prevalence of RHD diagnoses, by Indigenous status and year, 2016 to 2024

The prevalence of RHD increased at a similar relative rate for First Nations people and all Australians.

Source: AIHW analysis of National Rheumatic Heart Disease data collection. https://www.aihw.gov.au

Downloadable data tables are available on Data. See tables 4.5a and 4.5b.

Rheumatic heart disease priority status at most recent assessment

A person's priority status (Table 4.1) determines the recommended care plan to meet their medical and personal needs. This status may change over time as their condition and needs change. Priority definitions changed from the 2012 guidelines to the 2020 guidelines. Some people now require ongoing management that was not previously recommended. Both definitions are explained in Table 4.1. The time of application of these changes may vary between jurisdictions.

Priority 1 is assigned to people at greatest risk of disease recurrence/exacerbation and requires the most frequent follow up. Priority 4 is assigned to people with the lowest risk disease and involves the least frequent follow up.

Table 4.1: Definitions of RHD priority status
Priority level2012 Guideline2020 Guideline
Priority 1
  • Severe valvular disease or
  • Moderate/severe valvular lesions with symptoms or
  • Mechanical prosthetic valves; tissue prosthetic valves & valve repairs including balloon valvuloplasty
  • Severe RHD of any valve or
  • High risk post-valve surgical patients or
  • ≥ 3 episodes of acute rheumatic fever (ARF) within the last 5 years or
  • Pregnant women with RHD (of any severity) may be considered Priority 1 for the duration of the pregnancy or
  • Children ≤ 5 years of age with ARF or RHD
Priority 2Any moderate valve lesion in the absence of symptoms and with normal LV function
  • Moderate RHD of any valve or
  • Mild RHD involving both aortic and mitral valves or
  • Moderate risk post-valve surgical patients
Priority 3
  • ARF with no evidence of RHD or
  • Trivial to mild valvular disease
  • Mild RHD involving only a single valve or
  • ARF (probable or definite), currently prescribed secondary prophylaxis or
  • Borderline RHD currently prescribed secondary prophylaxis or
  • Low risk post-valve surgical patients
Priority 4Patients with a history of ARF (no RHD) for whom secondary prophylaxis has been ceased
  • History of ARF (possible, probable or definite) and completed secondary prophylaxis or
  • Borderline RHD not on secondary prophylaxis or
  • Resolved RHD and completed secondary prophylaxis

Note: Priority definitions have changed in the new guidelines released in 2025, but these data were collected using the 2020 definitions. Source: Adapted from The Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease 2020.

At the end of 2024, of the 5,867 First Nations people diagnosed with RHD and living in Queensland, Western Australia, South Australia or the Northern Territory, 4,465 (76%) had a priority status recorded at their most recent evaluation. Of these, 24% (1,087 people) were priority 1, 23% (1,010) were priority 2, 42% (1,875) were priority 3, and 11% (492) were priority 4 (Supplementary table 4.6).

Newly diagnosed rheumatic heart disease

In this report, a ‘new’ RHD diagnosis (incidence) is defined as one that was newly diagnosed in the relevant year. In most cases, it is not possible to identify a year of onset for RHD as the condition may be asymptomatic initially. The analysis is based on year of diagnosis.

In Queensland, Western Australia, South Australia and the Northern Territory:

  • there were 410 reports of new RHD diagnoses in 2024
  • about 73% (299 cases) of new RHD diagnoses were among First Nations people (Supplementary table 4.9)
  • one-third of new RHD was diagnosed in children under 15 (118 or 40% of First Nations cases and 135 or 33% of cases in all Australians) (Figures 4.5a and 4.5b; Supplementary tables 4.7a and 4.7b)
  • around two-thirds of new cases were diagnosed in females (188 or 63% of First Nations cases and 265 or 65% of cases in all Australians) (Supplementary tables 4.7a and 4.7b)
  • the Northern Territory had the highest diagnosis rate among First Nations people and all Australians (180 diagnoses per 100,000 population and 56 diagnoses per 100,000 population, respectively) (Figure 4.6; Supplementary tables 4.8)
  • for all Australians, diagnosis rates increased significantly between 2016 and 2018 from 3.7 to 5.5 diagnoses per 100,000 population and then decreased significantly to 3.9 diagnoses per 100,000 population in 2024 (Figure 4.7; Supplementary table 4.10b)
  • for First Nations people, the rate fluctuated between a low of 50.9 diagnoses per 100,000 population in 2016 and a high of 80.1 diagnoses per 100,000 population in 2018. The rate has been declining for the past few years, and decreased significantly from 76.8 diagnosis per 100,000 population in 2020 to 54.1 diagnoses per 100,000 population in 2024 (Figure 4.7; Supplementary table 4.10a). 

Figure 4.5a: Incidence of new RHD diagnoses among males, by age and Indigenous status, 2024

The incidence of new RHD decreased for both First Nations males and all Australian males until age 35-44 and then increased again. 

Source: AIHW analysis of National Rheumatic Heart Disease data collection. https://www.aihw.gov.au

Downloadable data tables are available on Data. See tables 4.7a and 4.7b.

Figure 4.5b: Incidence of new RHD diagnoses among females, by age and Indigenous status, 2024

There was no discernible pattern for the incidence of new RHD among First Nations females, but it decreased as age increased for all Australians.

Source: AIHW analysis of National Rheumatic Heart Disease data collection. https://www.aihw.gov.au

Downloadable data tables are available on Data. See tables 4.7a and 4.7b.

Figure 4.6: Incidence of new RHD diagnoses among First Nations people, by state or territory, 2024

Queensland, Western Australia, and South Australia had similar incidence rates while the Northern Territory was much higher.

Source: AIHW analysis of National Rheumatic Heart Disease data collection. https://www.aihw.gov.au

Downloadable data tables are available on Data. See Table 4.8.

Figure 4.7: Incidence of new RHD diagnoses in Qld, WA, SA, and NT, by Indigenous status and year, 2016 to 2024

The incidence of new RHD increased with a peak in 2018 for First Nations people and for all Australians followed by a general decrease.

Source: AIHW analysis of National Rheumatic Heart Disease data collection. https://www.aihw.gov.au

Downloadable data tables are available on Data. See tables 4.10a and 4.10b.

Severity of rheumatic heart disease is recorded at the time of diagnosis

Severity is collected at the time of diagnosis and can be categorised as severe, moderate, mild, or borderline, as determined by a specialist. Table 4.2 lists the definitions of each status. In reports published prior to 2023, severity and priority were combined to reflect the patient’s status and that was called severity. As such, previous reports do not have comparable data related to severity. Borderline RHD data were not available from some registers and the further availability of this category is to be determined by the new Australian RHD clinical guidelines.

Table 4.2: Definitions of rheumatic heart disease severity status
Severity statusDefinitions
SevereEchocardiogram showing:
  • severe regurgitation or severe stenosis of any valve or
  • combined moderate regurgitation and/or moderate stenosis of one or more valves or
  • past or impending valve repair or prosthetic valve replacement.
ModerateEchocardiogram showing:
  • moderate regurgitation or moderate stenosis of a single valve or
  • combined mild regurgitation and/or mild stenosis of one or more valves.
MildEchocardiogram showing:
  • mild regurgitation or mild stenosis of a single valve or
  • atrioventricular conduction abnormality on ECG during ARF episode.
BorderlineBorderline RHD on echocardiogram without a documented history of ARF (this diagnosis applies to people ≤20 years of age only)
ARF only/ No RHDARF with no evidence of RHD

AR = Aortic regurgitation

LA = left atrium

LV = left ventricle

MS = mitral stenosis

MR = mitral regurgitation

MV = mitral valve

Source: Adapted from Table 10.2 in The Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease

In 2024, of the 299 First Nations people with severity recorded at a new RHD diagnosis in Qld, WA, SA or NT:

No previous documented acute rheumatic fever

Rheumatic heart disease (RHD) occurs only in someone who has had acute rheumatic fever (ARF). Timely and accurate diagnosis of ARF is critical to reducing the risk of RHD as it will allow sufficient time for secondary prophylaxis to be effective. This also relies on timely diagnosis and treatment of Strep A infections.

Among the 299 First Nations people with a new RHD diagnosis in 2024, 79.3% (237 people) did not have a previous ARF episode recorded on the registers or were diagnosed with RHD within 90 days of their first recorded ARF episode (Supplementary table 4.12). This shows that in many cases, RHD might have been prevented by secondary prophylaxis, if ARF had been diagnosed and secondary prophylaxis commenced. 

ARF might not be recorded on a register for various reasons, such as:

  • being diagnosed before the relevant register began
  • being diagnosed prior to the condition being notifiable
  • the person being diagnosed in a jurisdiction that does not have a register
  • the episode was never diagnosed.

Surgery among First Nations people with rheumatic heart disease in Queensland, Western Australia, South Australia and the Northern Territory

For analysis purposes, a surgical event was included regardless of the year of RHD diagnosis, acknowledging that the years for which jurisdictions have been collecting data vary.

Refer to Table 2.1 for more information.

RHD leads to structural damage to the heart valves – most commonly the mitral valve. The aortic and tricuspid valves, and, rarely, the pulmonary valve, can also be affected. Surgery may be needed to replace or repair valves. Surgery may include prolonged hospitalisation, isolation from family, and ongoing regular monitoring. A person may have surgical events more than once on damaged valves and may have multiple procedures in one surgical event – that is, multiple valves repaired or replaced in a single surgery.

These figures reflect only those surgeries that were recorded in the registers and may not include all RHD-related surgery undertaken. However, comparison with data from the National Hospital Morbidity Database suggests that most RHD surgeries among First Nations people in Queensland, Western Australia, South Australia, and the Northern Territory are recorded on the registers (AIHW unpublished analysis). New South Wales was not included in this analysis.

In 2024, 146 people recorded on one of the registries in Queensland, Western Australia, South Australia, or the Northern Territory had surgery. Of those, 111 people were First Nations people who underwent 115 surgical events (Supplementary table 4.13). Of these First Nations people:

In 2024, of the 115 surgical events for First Nations people:

  • those aged 45 and over had the most surgical events (40), followed by those aged 25–34 (28)
  • 12 surgical events for RHD took place in children aged under 15 years (Figure 4.8; Supplementary table 4.13)

Figure 4.8: Surgical events among First Nations people with RHD, by age group, 2024

Surgery was most common among First Nations people 25 and over.

Source: AIHW analysis of National Rheumatic Heart Disease data collection. https://www.aihw.gov.au

Downloadable data tables are available on Data. See Table 4.13.